CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Retinal Neoplasms

Tumors or cancer of the RETINA.

Subtype terms (1)

More specific conditions that are subtypes of Retinal Neoplasms in the MeSH hierarchy.

  • Retinoblastoma

    57 drugs (34 approved, 23 experimental)

Drugs by status

Phase 3 trials (7)

  • doxorubicin
  • vincristine
  • carboplatin
  • cyclophosphamide
  • topotecan
  • etoposide
  • sargramostim

Phase 2 trials (1)

  • melphalan

Organizations

Organization Involved with Phase 3 Indications (2)

  • National Cancer Institute (NCI)
  • St. Jude Children's Hospital

Organization Involved with Phase 2 Indications (27)

  • Centre Leon Berard
  • Northwestern University
  • University of Bordeaux
  • University of Angers
  • University of Western Brittany
  • Bocage University
  • University of Limoges
  • Jean Monnet University
  • University of Strasbourg
  • Children Hospital of Toulouse
  • François Rabelais University
  • Adolphe Rothschild Ophtalmologic Foundation
  • University of Montpellier
  • Curie Institute
  • University of Lille
  • University of Reims
  • University of Nantes
  • University of Nice Sophia Antipolis
  • University of Poitiers
  • Aix-University of Marseille
  • University of Rennes
  • University of Grenoble
  • Rouen Normandy University
  • University of Caen-Normandie
  • University of Picardie Jules Verne
  • University of Lorraine
  • University Clermont Auvergne

ICD-10 crosswalk

  • C69.2 — Malignant neoplasm of retina

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.